XOMA Corp
- CIK: 0000791908
- EIN: 52-2154066
- Business address: 2200 POWELL STREET, SUITE 310, EMERYVILLE, California, 94608
Information
Mailing address
2200 POWELL STREET, SUITE 310, EMERYVILLE, CA, 94608Phone
510-204-7239State location
CaliforniaState of incorporation
N/AFiscal year end
December 31SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONSFilings
N/A
About XOMA Corp
XOMA Corp (CIK: 0000791908) is an American company incorporated in the state of California. Head office is located at 2200 POWELL STREET, SUITE 310, EMERYVILLE, California, 94608. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. XOMA Corp is a public company and trade via Over-The-Counter (OTC).Old names:
- XOMA LTD /DE/ from 2001-13-Dec to 2012-17-Jan
- XOMA CORP /DE/ from 1996-23-Apr to 1998-19-Mar
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Hughes Owen | 0001575933 | Jan-03-2023 | director, officer: Interim CEO |
| Sitko Bradley | 0001959809 | Jan-03-2023 | officer: Chief Investment Officer |
| Franklin Heather L | 0001436658 | Aug-06-2021 | director |
| Hernday Natasha | 0001780547 | Jun-30-2020 | director |
| BVF I GP LLC | 0001803805 | Mar-13-2020 | 10 percent owner |
| BVF II GP LLC | 0001803806 | Mar-13-2020 | 10 percent owner |
| BVF GP HOLDINGS LLC | 0001803809 | Mar-13-2020 | 10 percent owner |
| Kosacz Barbara | 0001763316 | Jan-01-2019 | director |
| DATTA DEEPSHIKHA | 0001731721 | Feb-14-2018 | officer: Chief Business Officer |
| PERRY MATTHEW D | 0001454337 | Feb-16-2017 | director, other: See Explanation of Responses |
| BIOTECHNOLOGY VALUE FUND L P | 0000918923 | Feb-10-2017 | other: See Explanation of Responses |
| BVF PARTNERS L P/IL | 0001055947 | Feb-10-2017 | 10 percent owner |
| BVF INC/IL | 0001056807 | Feb-10-2017 | 10 percent owner |
| BIOTECHNOLOGY VALUE FUND II LP | 0001102444 | Feb-10-2017 | other: See Explanation of Responses |
| LAMPERT MARK N | 0001233840 | Feb-10-2017 | 10 percent owner |
| Biotechnology Value Trading Fund OS LP | 0001660683 | Feb-10-2017 | other: See Explanation of Responses |
| BVF Partners OS Ltd. | 0001660684 | Feb-10-2017 | other: See Explanation of Responses |
| BURNS THOMAS M. | 0001638479 | Apr-03-2015 | officer: Chief Financial Officer |
| HUTT PETER BARTON | 0001171527 | May-22-2014 | director |
| LIMBER JOSEPH M | 0001216023 | Mar-10-2014 | director |
| Neal James R | 0001600865 | Feb-27-2014 | officer: VP Business Development |
| Klein Thomas | 0001572521 | Dec-31-2013 | officer: Chief Commercial Officer |
| WYSZOMIERSKI JACK L | 0001023225 | Nov-13-2013 | director |
| VAN NESS W DENMAN | 0001221676 | Nov-13-2013 | director |
| BOWES WILLIAM K JR | 0001225476 | Nov-13-2013 | director |
| KURLAND FRED | 0001267273 | Nov-13-2013 | officer: CFO & VP Finance |
| Walbert Timothy P | 0001349376 | Nov-13-2013 | director |
| RUBIN PAUL D | 0001210905 | Aug-14-2013 | officer: Sr. VP Clinical Dev. & CMO |
| SCANNON PATRICK J MD PHD | 0001222790 | Aug-14-2013 | director, officer: Exec. VP & CSO |
| Varian John | 0001416176 | Jul-15-2013 | director, officer: Director and CEO |
| Baker Bros. Advisors (GP) LLC | 0001580575 | Jul-01-2013 | director, 10 percent owner |
| Baker Brothers Life Sciences LP | 0001363364 | Jul-19-2012 | director |
| 14159, L.P. | 0001551138 | Jul-19-2012 | director |
| 667, L.P. | 0001551139 | Jul-19-2012 | director |
| Neu Kelvin | 0001554699 | Jul-19-2012 | director |
| BAKER BROS ADVISORS LLC | 0001263508 | Apr-12-2012 | 10 percent owner |
| BAKER JULIAN | 0001087939 | Mar-06-2012 | 10 percent owner |
| BAKER FELIX | 0001087940 | Mar-06-2012 | 10 percent owner |
| Baker Biotech Capital (GP), LLC | 0001244389 | Mar-06-2012 | 10 percent owner |
| Baker Brothers Life Sciences Capital (GP), LLC | 0001307729 | Mar-06-2012 | 10 percent owner |
| 14159 capital (GP), LLC | 0001317493 | Mar-06-2012 | 10 percent owner |
| ZENNER PATRICK J | 0001139036 | Jul-22-2010 | director |
| ENGLE STEVEN B | 0001234368 | Aug-03-2007 | director, officer: CEO and President |
| FISHER CHARLES J JR | 0001408469 | Jul-25-2007 | director |
| BOYLE J DAVID II | 0001331152 | Jun-30-2005 | officer: VP, Finance, and CFO |
| DELLIO CLARENCE L | 0001221680 | Dec-31-2003 | officer: Sr VP, Operations and COO |
| MARGOLIN CHRISTOPHER J | 0001222791 | Dec-31-2003 | officer: VP, General Counsel & Sec'y |
| CASTELLO JOHN L | 0001222786 | Nov-04-2003 | director, officer: Chairman, CEO & President |
| DAVIS PETER B | 0001222789 | Jun-30-2003 | officer: VP, Finance & CFO |
| ANDRESS JAMES G | 0001014093 | May-22-2003 | director |
| MENDELL STEVEN C | 0001222009 | May-22-2003 | director |
| KORNBERG ARTHUR MD | 0001222045 | May-22-2003 | director |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by XOMA Corp
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 8-K | Document | Current report filing Acc-no: 0001193125-24-176579 (34 Act) Size: 196 KB |
Jul-09-2024 | 241106361 |
| EFFECT | Document | Acc-no: 9999999995-24-001871 (33 Act) Size: 1 KB | Jun-17-2024 | 241050080 |
| EFFECT | Document | Acc-no: 9999999995-24-001870 (33 Act) Size: 1 KB | Jun-17-2024 | 241050078 |
| 8-K/A | Document | Amendment to Current report filing Acc-no: 0001193125-24-160743 (34 Act) Size: 488 KB |
Jun-13-2024 | 241041701 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-150435 (34 Act) Size: 184 KB |
May-30-2024 | 241006167 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-24-009519 ( Act) Size: 5 KB |
May-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-24-009518 ( Act) Size: 5 KB |
May-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-24-009517 ( Act) Size: 5 KB |
May-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-24-009522 ( Act) Size: 5 KB |
May-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-24-009521 ( Act) Size: 7 KB |
May-17-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001214659-24-009520 ( Act) Size: 5 KB |
May-17-2024 | |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-140003 (34 Act) Size: 199 KB |
May-16-2024 | 24953569 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-134777 (34 Act) Size: 319 KB |
May-09-2024 | 24928625 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001558370-24-007470 (34 Act) Size: 10935 KB |
May-09-2024 | 24928597 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-123689 (34 Act) Size: 222 KB |
Apr-30-2024 | 24894053 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-111613 (34 Act) Size: 210 KB |
Apr-25-2024 | 24873098 |
| 8-K | Document | Current report filing Acc-no: 0001193125-24-085545 (34 Act) Size: 376 KB |
Apr-03-2024 | 24817087 |
| SC TO-T/A | Document | Amendment to Third party tender offer statement Acc-no: 0001193125-24-085519 ( Act) Size: 42 KB |
Apr-03-2024 | |
| ARS | Document | Annual report to security holders Acc-no: 0001193125-24-084098 (34 Act) Size: 4643 KB |
Apr-02-2024 | 24812250 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001193125-24-084088 (34 Act) Size: 419 KB |
Apr-02-2024 | 24812237 |
Recent 20 filings. View all XOMA Corp filings
Reviews
Pelisari
young lad who new his job ansered questions and new what was best for me.
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Frequently Asked Questions
Tags:
- XOMA Corp overview
- XOMA Corp job
- XOMA Corp stock
- XOMA Corp ownership
- XOMA Corp CEO
- XOMA Corp documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024
Telix Pharmaceuticals Ltd
Update: May 18, 2024
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 